Dr. Reisman is the founder and Director of the New York Cardiac Diagnostic Center which has a patient focused philosophy. When you visit one of our convenient Manhattan locations for either a daytime or evening appointment, you will experience an unmatched level of comfort and compassion along with high quality expertise. What sets us apart from other practices is a philosophy based on several premises. First, we function as a “concierge” style practice with individual attention and ease of setting up...Read More
Dr. Reisman is the founder and Director of the New York Cardiac Diagnostic Center which has a patient focused philosophy. When you visit one of our convenient Manhattan locations for either a daytime or evening appointment, you will experience an unmatched level of comfort and compassion along with high quality expertise. What sets us apart from other practices is a philosophy based on several premises. First, we function as a “concierge” style practice with individual attention and ease of setting up appointments and consultations but accept most insurance plans. Secondly, we have several locations in Manhattan to make it easier for you to have the initial consultation. Thirdly, we offer both daytime and evening appointments. Lastly, we specialize in diagnostic testing and can utilize the top experts in your evaluation.
Dr. Reisman is a Cardiologist and a nationally recognized Nuclear Cardiologist who was part of the team at the Cedars-Sinai Medical Center in Los Angeles instrumental in developing many of the early techniques in nuclear cardiology. Dr. Reisman was part of a group of select investigators with the Food And Drug Administration evaluating intravenous dipyridamole thallium testing prior to approval of this technique for general use in patients who cannot exercise.
Dr. Reisman has authored or co-authored numerous publications and has presented original research results at both the American College of Cardiology annual meetings and the American Heart Association annual meetings related to early detection of “high risk” heart disease, the evaluation of patients without symptoms with underlying heart blockages including those with “silent ischemia”, the prognosis of patients with blockages, use of dipyridamole thallium testing in patients who cannot exercise to identify severe blockages, detection of severe coronary artery disease in the elderly, and the evaluation of heart disease in patients who cannot walk secondary to a circulatory problem.
Reisman S.: Myocardial perfusion imaging with thallium-201 in the detection and assessment of coronary artery diseases. In: Cardiovascular Nuclear Medicine, (Lyons K.,ed), Appleton Century and Crofts, East Norwalk, Conn. 1988.
Reisman S.: Myocardial perfusion imaging with thallium-201 in the detection and assessment of coronary artery diseases. In: Cardiovascular Nuclear Medicine, (Lyons K.,ed), Appleton Century and Crofts, East Norwalk, Conn. 1988.
Reisman S, Berman D, Maddahi J, Swan HJC: The severe stress thallium defect: An indicator of critical coronary stenosis. Am Heart J 110:128-134, 1985.
Reisman S: Dipyridamole thallium testing: An alternative form of stress testing in patients unable to exercise. Chest (editorial) 88:321-322, 1985.
Reisman S, Maddahi J, Van Train K, Garcia E, Berman D: Quantitation of extent depth and severity of planar thallium defects in patients undergoing exercise thallium-201 scintigraphy. J Nucl Med 27: 1273-1281, 1986.
Reisman S, Shellock FG, Shah PK, Berman D, Swan HJC: Relationship between early electrocardiographic changes and left ventricular function in acute transmural anterior myocardial infarction. Clin Res 31(1): 16A, 1983.
Reisman S, Maddahi J, Swan HJC, Berman D: In patients with a strongly positive exercise electrocardiogram does longer exercise duration mean less extensive ischemia? J Am Coll Cardiol 1(2): p 649, 1983.
Reisman S, Berman D, Maddahi J, Swan HJC, Waxman A: Grading the severity of stress thallium-201 defects: Angiographic correlates. J Nucl Med 25(5): p 86, 1984.
Reisman S, Berman D, Maddahi J, Swan HJC: Exertional hypotension: Thallium scintigraphic and angiographic correlates. Circulation 70(4): p 157, 1984.
Reisman S, Berman DS, Maddahi H, Swan HJC: Silent myocardial ischemia during treadmill exercise: Thallium scintigraphic and angiographic correlates. J Am Coll Cardiol 5(2): p 406, 1985.
Reisman S, Berman DS, Maddahi J, Swan HJC: Silent myocardial ischemia vs. exertional angina: Equal extent and severity of thallium-201 abnormalities and frequency of left main stenosis. Clin Res 33(2): 220A, 1985.
Reisman S, Ladenheim M, Staniloff H, Rozanski A, Berman DS: Prognostic implication of silent ischemia in patients undergoing exercise thallium-201 scintigraphy. Clin Nucl Med 10(9S): p 12, 1985.
Reisman S, Ladenheim M, Staniloff HM, Rozanski A, Berman DS: Asymptomatic patients with exercise thallium-201 hypoperfusion: Identification of a high-risk subset. Circulation 72(3): p 445, 1985
Reisman S, Rozanski A, Maddahi J, Berman D: Prolonged post-exercise ST segment depression is an indicator of hemodynamically severe and extensive coronary artery disease (CAD). JACC 7(2): 163A, 1986.
Reisman S, Maddahi J, Van Train K, Garcia E, Berman D: A computerized method for quantification of extent, depth and severity of defects in patients undergoing exercise planar thallium-201 scintigraphy. J Nucl Med 27(6): p 953, 1986.
Reisman S, Ladenheim M, Staniloff HM, Berman DS: Prognostic stratification of asymptomatic patients by exercise T1-201 scintigraphy: Comparison to patients with typical angina. J Nucl Med 27(6): p 954, 1986.
Reisman S, Maddahi J, Berman D: In patients with high-risk coronary artery disease and T1-201 ischemia, is exertional angina meaningful? J Nucl Med 27(6): p 998, 1986.
Reisman S, Rozanski A, Maddahi J, Berman D: Thallium scintigraphic and coronary arteriographic correlates of prolonged post-exercise ST segment depression. J Nucl Med 27(6): p 998, 1986.
Reisman S, Klepser C, Chandramouly B, Konka S, Sacchi T: Silent myocardial ischemia in patients undergoing intravenous dipyridamole thallium-201 scintigraphy. J Nucl Med 28(4): p 580, 1987.
Reisman S, Klepser C, Vaugeois JC, Burgess C, Chandramouly B: Dipyridamole-induced increase in pulmonary thallium uptake: Marker of transient global left ventricular dysfunction in patients unable to exercise. JACC 11(2): p 214A, 1988.
Reisman S, Klepser C, Vaugeois JC, Sacchi T, Konka S,: ST segment depression during intravenous dipyridamole thallium infusion: Identification of patients with extensive jeopardized myocardium. J Nucl Med 29(5): p 782, 1988.
Reisman S, Klepser C, Vaugeois JC, Chandramouly B,: Intravenous dipyridamole thallium imaging in patients 70 years old or greater: A safe and effective technique in the elderly: J Nucl Med 29(5): p 953, 1988.
Reisman S, Klepser C, et al: Severe and extensive coronary artery disease in the elderly: Detection by intravenous dipyridamole thallium imaging. Circulation 78(4): p 333, 1988.
Reisman S, Klepser C, Sacchi T, Konka S: Dipyridamole-induced ST segment depression: Identification of extensive jeopardized myocardium. Circulation 78(4): p 108, 1988.
Reisman S, Goldsmith J, Franco CD, Wengerter KR, Gupta SK, Veith FJ: Combined intravenous dipyridamole thallium-201 and resting radionuclide ventriculography in risk stratification prior to vascular surgery. J Cardiovasc Surg 32(4): p 3, 1991.
